0001178913-19-001082.txt : 20190408 0001178913-19-001082.hdr.sgml : 20190408 20190408161330 ACCESSION NUMBER: 0001178913-19-001082 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190408 FILED AS OF DATE: 20190408 DATE AS OF CHANGE: 20190408 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BEN-YORAM ISRAEL CENTRAL INDEX KEY: 0001320556 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31392 FILM NUMBER: 19737588 MAIL ADDRESS: STREET 1: 24 BARKAN STREET CITY: RISHON LEZION STATE: L3 ZIP: 00000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PLURISTEM THERAPEUTICS INC CENTRAL INDEX KEY: 0001158780 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 980351734 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: MATAM ADVANCED TECHNOLOGY PARK STREET 2: BUILDING NO. 5 CITY: HAIFA STATE: L3 ZIP: 3508409 BUSINESS PHONE: 972-74-710-7171 MAIL ADDRESS: STREET 1: MATAM ADVANCED TECHNOLOGY PARK STREET 2: BUILDING NO. 5 CITY: HAIFA STATE: L3 ZIP: 3508409 FORMER COMPANY: FORMER CONFORMED NAME: PLURISTEM LIFE SYSTEMS INC DATE OF NAME CHANGE: 20030701 FORMER COMPANY: FORMER CONFORMED NAME: AI SOFTWARE INC DATE OF NAME CHANGE: 20010906 4 1 zk1922906.xml OWNERSHIP DOCUMENT X0306 4 2019-04-08 0 0001158780 PLURISTEM THERAPEUTICS INC PSTI 0001320556 BEN-YORAM ISRAEL MATAM PARK, BUILDING #5 HAIFA L3 3508409 ISRAEL 1 0 0 0 Common Stock 2019-04-08 4 P 0 71429 0.70 A 387235 D Common Stock 411250 I By Eshed Dash Ltd. Common Stock Warrant 0.70 2019-04-08 4 P 0 71429 0 A 2019-04-08 2024-04-08 Common Stock 71429 71429 D The common stock and common stock warrant were acquired in the issuer's public underwritten offering of units, in which each unit consisted of one share of common stock and an accompanying common stock warrant to purchase one share of common stock, at a price of $0.70 per unit. The price paid per unit is reflected in Table I. The common stock warrants were exercisable immediately upon their issuance. /s/ Israel Ben-Yoram 2019-04-08